BOI:EPA
Boiron USA
19,05 €
arrow_downward
-1,04%(-0,20) 1D
12 նոյ, 17:35:20 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Open
19,10 €
High
19,25 €
Low
18,85 €
Mkt. cap
334,24 մլն
Avg. vol.
5,04 հզր
Volume
660,00
P/E ratio
12,63
52-wk high
32,25 €
52-wk low
16,90 €
EPS
1,51 €
Shares outstanding
17,55 մլն
No. of employees
3 հզր
Open
19,10 €
High
19,25 €
Low
18,85 €
Mkt. cap
334,24 մլն
Avg. vol.
5,04 հզր
Volume
660,00
P/E ratio
12,63
52-wk high
32,25 €
52-wk low
16,90 €
EPS
1,51 €
Shares outstanding
17,55 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
Foreign Policy Journal
·
18 րոպե առաջ
SoundHound AI (NASDAQ: SOUN) Shares Slide 22% As $120M Savings Drive Targets 2027 Profitability
CNBC
·
58 րոպե առաջ
Watch these levels to know if Nasdaq-100 is set to break out
The Motley Fool
·
2 ժամ առաջ
The S&P 500 Is Hiding a Sneaky Risk. Here's How Investors Can Prepare for Potential Volatility.
Barron's
·
2 ժամ առաջ
You Don’t Need Nvidia to Beat the S&P 500. These ETFs Prove It.
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron USA